Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

668 ARTÍCULOS , VIENDO DEL 271 AL 285

Cerebellar and prefrontal cortex contributions to adaptation, strategies, and reinforcement learning

Taylor JA, Ivry RB.

Prog Brain Res. 2014;210:217-53. doi: 10.1016/B978-0-444-63356-9.00009-1.

Dysregulation of cellular iron metabolism in Friedreich ataxia: from primary iron-sulfur cluster deficit to mitochondrial iron accumulation

Martelli A, Puccio H.

Front Pharmacol. 2014 Jun 3;5:130. doi: 10.3389/fphar.2014.00130. eCollection 2014.

Epigenetic-based therapies for Friedreich ataxia

Sandi C, Sandi M, Anjomani Virmouni S, Al-Mahdawi S, Pook MA.

Front Genet. 2014 Jun 3;5:165. doi: 10.3389/fgene.2014.00165. eCollection 2014.

Treatment Options in Degenerative Cerebellar Ataxia: A Systematic Review

Sarva H, Shanker VL.

Mov Disord Clin Pract. 2014 Jun 12;1(4):291-298. doi: 10.1002/mdc3.12057. eCollection 2014 Dec.

Solitary cystic cerebellar metastasis in a patient with invasive transitional cell carcinoma of the bladder

Vaa B, Kohli M, Price KA, Swetz KM.

BMJ Case Rep. 2014 Jun 11;2014:bcr2013200137. doi: 10.1136/bcr-2013-200137.

[Pediatric medulloblastoma presenting as cerebellar hemorrhage: a case report]

Furuhata M, Aihara Y, Eguchi S, Horiba A, Tanaka M, Komori T, Okada Y.

No Shinkei Geka. 2014 Jun;42(6):545-51.

Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease

Dale RC, Brilot F, Duffy LV, Twilt M, Waldman AT, Narula S, Muscal E, Deiva K, Andersen E, Eyre MR, Eleftheriou D, Brogan PA, Kneen R, Alper G, Anlar B, Wassmer E, Heineman K, Hemingway C, Riney CJ, Kornberg A, Tardieu M, Stocco A, Banwell B, Gorman MP, Benseler SM, Lim M.

Neurology. 2014 Jul 8;83(2):142-50. doi: 10.1212/WNL.0000000000000570. Epub 2014 Jun 11.

Paraneoplastic downbeat nystagmus associated with cerebellar hypermetabolism especially in the nodulus

Choi SY, Park SH, Kim HJ, Kim JS.

J Neurol Sci. 2014 Aug 15;343(1-2):187-91. doi: 10.1016/j.jns.2014.05.030. Epub 2014 Jun 2.

Ataxia plus myoclonus in a 23-year-old patient due to STUB1 mutations

Cordoba M, Rodriguez-Quiroga S, Gatto EM, Alurralde A, Kauffman MA.

Neurology. 2014 Jul 15;83(3):287-8. doi: 10.1212/WNL.0000000000000600. Epub 2014 Jun 13.

Conjoint occurrence of GABAB receptor antibodies in Lambert-Eaton myasthenic syndrome with antibodies to the voltage gated calcium channel

Dogan Onugoren M, Rauschka H, Bien CG.

J Neuroimmunol. 2014 Aug 15;273(1-2):115-6. doi: 10.1016/j.jneuroim.2014.05.011. Epub 2014 May 29.

A novel de novo mutation of the TITF1/NKX2-1 gene causing ataxia, benign hereditary chorea, hypothyroidism and a pituitary mass in a UK family and review of the literature

Veneziano L, Parkinson MH, Mantuano E, Frontali M, Bhatia KP, Giunti P.

Cerebellum. 2014 Oct;13(5):588-95. doi: 10.1007/s12311-014-0570-7.

WWOX at the crossroads of cancer, metabolic syndrome related traits and CNS pathologies

Aldaz CM, Ferguson BW, Abba MC.

Biochim Biophys Acta. 2014 Aug;1846(1):188-200. doi: 10.1016/j.bbcan.2014.06.001. Epub 2014 Jun 14.

[Whipple's disease and Tropheryma whipplei infections in internal medicine. When to think about it? How to treat?]

Lagier JC, Fenollar F, Raoult D.

Rev Med Interne. 2014 Dec;35(12):801-7. doi: 10.1016/j.revmed.2014.04.016. Epub 2014 Jun 2.

Spinocerebellar ataxia type 10 in Peru: the missing link in the Amerindian origin of the disease

Leonardi L, Marcotulli C, McFarland KN, Tessa A, DiFabio R, Santorelli FM, Pierelli F, Ashizawa T, Casali C.

J Neurol. 2014 Sep;261(9):1691-4. doi: 10.1007/s00415-014-7394-8. Epub 2014 Jun 17.

12q24 locus association with type 1 diabetes: SH2B3 or ATXN2?

Auburger G, Gispert S, Lahut S, Omür O, Damrath E, Heck M, Başak N.

World J Diabetes. 2014 Jun 15;5(3):316-27. doi: 10.4239/wjd.v5.i3.316.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias